Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIROGACESTAT HYDROBROMIDE vs NITRENDIPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIROGACESTAT HYDROBROMIDE vs NITRENDIPINE: Safety Overview

Metric NIROGACESTAT HYDROBROMIDE NITRENDIPINE
Total FAERS Reports 166 353
Deaths Reported 0 13
Death Rate N/A 3.7%
Hospitalizations 18 243
Average Patient Age 46.8 yrs 70.9 yrs
% Female Patients 63.0% 41.9%
FDA Approval Date Apr 4, 2024 N/A
Marketing Status Prescription N/A